Publications by authors named "Bergantim Rui"

Claim this Profile
[
[Diagnosis and Laboratory Follow-Up of Patients with Multiple Myeloma: Guidelines from the Portuguese Multiple Myeloma Group].
Ana Marta Pires, João Pedro Barreto, Joana Caetano, Maria José Soares, Catarina Geraldes, Rui Henrique, Rui Bergantim

Acta Med Port· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma Laboratory Diagnostics Made Simple: Practical Insights and Key Recommendations.
Ana Marta Pires, João Pedro Barreto, Joana Caetano, Maria José Soares, Catarina Geraldes, Rui Henrique, Rui Bergantim

J Clin Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the preclinical design and assessment of CAR-T cells.
Radu Tomai, Javier De Las Rivas, Bogdan Fetica, Rui Bergantim, Brankica Filipic

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib-Associated Thrombotic Microangiopathy in a Multiple Myeloma Patient: Complement Genetic Alterations Impact and Eculizumab Therapy.
Joana Lopes, Vítor Fernandes, Nuria Paulo, Pedro Lisboa Gonçalves, Rafael Figueiredo, Rui Bergantim

Cureus· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study.
Rui Bergantim, Sara Peixoto da Silva, Vanessa Pinto, Joana M Pereira, Diana Sousa

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridium perfringens Sepsis Complicated by Hepatic Abscess Following Intensive Chemotherapy in Mixed-Phenotype Acute Leukemia.
Pedro Baptista, Marta Henriques, Mariana Miranda, Rui Bergantim, Fernanda Trigo

Cureus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving treatment landscape of multiple myeloma in Portugal: A nation-wide retrospective cohort study of real-world clinical practice.
Rui Bergantim, Catarina Geraldes, Cristina João, Paulo Lúcio, Manuel Neves

EJHaem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Rui Bergantim

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Rui Bergantim

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study.
Arnaud Jaccard, Frank Bridoux, Wilfried Roeloffzen, Monique C Minnema, Rui Bergantim

Clin Lymphoma Myeloma Leuk· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri, Rui Bergantim

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis.
Rita Pereira, Rui Bergantim

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma.
Catarina Geraldes, Adriana Roque, Ana Bela Sarmento-Ribeiro, Manuel Neves, Alina Ionita, Rui Bergantim

Front Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, Rui Bergantim, Francesca Farina

Hematol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Giuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, Francesco Marchesi, Julio Dávila-Valls, Rui Bergantim

Int J Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsing COVID-19 in a Patient With Non-Hodgkin Lymphoma on Chemotherapy.
António Carujo, Luís Ferreira, Rui Bergantim, André Santos Silva, António Ludgero Vasconcelos

Cureus· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and referral of patients with AL amyloidosis in Portugal: results from a Delphi panel.
Rui Bergantim, André Caetano, Francisco F Silva, Isabel Tavares, Manuela Ferreira

Porto Biomed J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portuguese consensus on the prevention and treatment of nausea and vomiting induced by cancer treatments.
Cláudia Vieira, Rui Bergantim, Elsa Madureira, Juan C M Barroso, Miguel Labareda

Porto Biomed J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Multiple Myeloma Treatment Guidelines by the Portuguese Group of Multiple Myeloma].
Cristina João, Rui Bergantim, Joana Santos, Celina Afonso, Paulo Bernardo

Acta Med Port· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimum Methotrexate Exposure in Patients With Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review.
Monteiro Joaquim Faria, Damas Rita, Bergantim Rui, Trigo Fernanda

Ther Drug Monit· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement.
Catarina Oliveira-Silva, Nídia Marques, Ana Pinho, Rui Poínhos, Rui Bergantim

Nephron· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, Luisa Verga, Federico Itri, Rui Bergantim

Ther Adv Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.
Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Rui Bergantim

Blood Cancer J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Federico Itri, Rui Bergantim

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients-A Proof of Concept.
Rui Bergantim, Sara Peixoto da Silva, Bárbara Polónia, Mélanie A G Barbosa, André Albergaria

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis